VANCOUVER, March 31 /CNW/ - Merus Labs International Inc. is pleased to announce the appointment of Moira Ong, CA, CFA, to position of Chief Financial Officer. Ms. Ong has more than 10 years experience in public company accounting and audit reporting. From 2005 until 2010, Ms. Ong was the senior Manager at Grant Thornton, LLP in charge of completion of financial statements for Canadian publicly listed companies in addition to serving as Financial Consultant for strategic Income Security Services from 2003 to 2005. Ms. Ong was an audit manager in the Banking and Securities group at Deloitte & Touche LLP in New York from 2000 to 2003 and served as the Senior Accountant for Grant Thornton LLP from 1996 to 2000. Ms. Ong obtained her CA designation in 1999 and her CFA designation in 2003.
About Merus Labs: Merus Labs is a specialty pharmaceutical company engaged in acquisition and licensing of specialty branded Rx and OTC pharmaceutical products. Merus further enhances the sale and distribution of these products by introduction of a focused marketing and promotion plan.
MERUS LABS INTERNATIONAL INC.
Ahmad Doroudian, President
This news release contains certain statements that may be deemed "forward-looking statements". Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on beliefs, estimates and opinions of management on the date the statements are made. We undertake no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change, except as required by law.
SOURCE Merus Labs International Inc.
For further information: For further information: Ahmad Doroudian, Telephone: (604) 805-7783, Email: email@example.com